This is my DIA 2016 poster on how digital health networks in China can potential help reshape perceptions and correct misconceptions for clinical trials.

1. 1
Digital health networks as change agents of public
perceptions for clinical trials
Jessie Lee
Associate Director, Site & Patient Networks
Quintiles

2. 2
The views and opinions expressed in the following PowerPoint slides
are those of the individual presenter and should not be attributed to
Drug Information Association, Inc. (“DIA”), its directors, officers,
employees, volunteers, members, chapters, councils, Communities or
affiliates, or any organization with which the presenter is employed or
affiliated.
These PowerPoint slides are the intellectual property of the individual
presenter and are protected under the copyright laws of the United
States of America and other countries. Used by permission. All rights
reserved. Drug Information Association, Drug Information Association
Inc., DIA and DIA logo are registered trademarks. All other trademarks
are the property of their respective owners.
Disclaimer

3. 3
Web and mobile based platforms have made healthcare
(including clinical trial) information easily accessible for
consumers seeking answers for their medical questions in the
virtual space
Healthcare Communication & Clinical Trials
PC
platform
42%
mApp
platform
58%
2015 H1
Digital Health
Platform Usage
Frequency in
China
6.04bil
When searching for information
about a newly developed
condition, patients would
first research online
ONSET OF SYMPTOMS
60% 30% 50%
MEDICAL CONSULT
Consults physicians F2F or e-
Consult via websites/mobile
apps
RETURNING TO SEARCH
Research diagnosis or
prescribed treatment online
65%
41% 23%
SELF-MANAGED HEALTHCARE
Use mApps to manage
conditions e.g. reminders to
take medication
MONITOR & TRACK
Willingness to use
wearable devices to
manage patient health

4. 4
By analyzing the ‘Digital Patient’ journey and digital health
networks most heavily trafficked for patient population targeted in
a clinical trial, companies can glean patient insights that are
important to consider and include in recruitment strategies or
clinical trial designs
Online conversations revealed that reliable sources of clinical trial
information is not always readily available
Insights from ‘social listening’

5. 5
Analysis of conversations on digital health platforms help identify
gaps in information flow, barriers to enrollment and motivational
drivers etc.
Changing Public Perceptions of Clinical Trials
Patient engagement strategies can
then be designed to ensure that
the perceptions that patients &
caregivers have of clinical trials
and decisions to participate in
trials (or not) are evidence-based
and obtained from official sources

6. 6
Jessie Lee
Associate Director, Site & Patient Networks
Quintiles
Thank You